Wall Street Times

New York Cryogen’s Expansion and the AMA Endorsement: A Glimpse into the Future of Pain Management

Image commercially licensed from: https://unsplash.com/photos/a-person-holding-another-persons-hand-on-a-bed-05AYWrBNwtA
Image commercially licensed from: https://unsplash.com/photos/a-person-holding-another-persons-hand-on-a-bed-05AYWrBNwtA

New York Cryogen has emerged as a pioneering force, revolutionizing the realm of pain management. With its recent endorsement by the American Medical Association (AMA) and a strategic expansion plan, this innovative company is setting the stage for a promising future where pain management is redefined and patient care is optimized.

A Pioneer in Pain Management

Founded by Gregory Papageorge, New York Cryogen was established with the mission of delivering cutting-edge pain relief and recovery solutions. From its inception in November 2021, the company’s journey has been marked by dedication to improving the lives of those in need of pain management.

Mr. Papageorge’s 24-year career in healthcare sales, with a focus on complex spine solutions, provided him with a unique perspective on pain management. It was this wealth of experience that paved the way for the development of a groundbreaking technology, high-pressure medical cryotherapy, which addresses pain at its core by penetrating tissues effectively. This innovation is not only reshaping the field of pain management but also extending its influence to the broader realm of medicine.

The Significance of the AMA Endorsement

A historic moment in the world of cryotherapy, New York Cryogen’s high-pressure medical cryotherapy has earned the endorsement of the American Medical Association. This endorsement signifies not only the safety and efficacy of this revolutionary approach but also its potential to transform the landscape of pain management.

The AMA’s approval serves as a beacon of hope, motivating healthcare providers and professionals to explore high-pressure cryotherapy as a medical procedure. It lends credibility to a novel pain relief modality, opening doors for its integration into mainstream medical practice. Patients can now confidently seek high-pressure cryotherapy treatments knowing they are supported by a well-established medical authority.

Accepting Healthcare Insurance: A Milestone in Accessibility

What sets New York Cryogen apart from other cryotherapy providers is its ability to accept healthcare insurance for high-pressure cryotherapy treatments. This achievement not only makes pain relief accessible to a wider audience but also empowers individuals to become certified medical providers for this transformative modality. Patients can now explore high-pressure cryotherapy without the burden of high out-of-pocket costs, making it a viable and attractive option for those in need of pain management.

The inclusion of high-pressure cryotherapy in healthcare insurance programs represents a significant step toward making cutting-edge medical treatments more accessible and affordable. This milestone paves the way for a future where advanced therapies are not limited to the privileged few but are within reach for a broader spectrum of patients.

An Expansive Vision

New York Cryogen’s vision extends beyond pain management alone. The company is deeply committed to the development of medical devices for high-pressure cryotherapy, with the AC-130 Viper leading the way as the first of its kind in the world. This technology has taken a leap forward and gained recognition from Medicare, Medicaid, and private insurance providers. Integration is already in progress across several states, marking a remarkable expansion in the accessibility of high-pressure cryotherapy.

The strategic expansion plan for 2023 and 2024 is set to include Hawaii and Puerto Rico, bringing this revolutionary technology to even more regions. Looking ahead, New York Cryogen’s ambitions stretch beyond U.S. borders. The company plans to introduce its transformative high-pressure cryotherapy technology in Canada, the United Kingdom, and other European countries within the 6-8 months. 

This ambitious expansion is not only a testament to the growing demand for innovative pain management solutions but also a testament to the company’s commitment to improving the lives of people worldwide.

The Impact on Pain Management and Medicine

The high-pressure medical cryotherapy technology developed by New York Cryogen has the potential to change the way we approach pain management and medicine as a whole. Its endorsement by the AMA, acceptance by healthcare insurance providers, and strategic expansion plans signify a shift toward more accessible, effective, and patient-centric pain relief options.

This innovative approach addresses pain at its source by effectively penetrating tissues, offering a level of targeted relief that was previously challenging to achieve. Its ability to minimize inflammation and provide rapid pain relief positions it as a game-changing modality.

As New York Cryogen’s technology gains traction, its impact on pain management and medicine is likely to be profound. Patients can expect more accessible and affordable pain relief options, while healthcare providers can look forward to incorporating cutting-edge, AMA-endorsed therapy into their medical practices.

Clinical Trials and Real-World Evidence

The effectiveness of high-pressure medical cryotherapy is not mere theory; it is supported by substantial evidence. Clinical and observational trials, conducted by Mr. Papageorge himself, have provided robust data on the technology’s impact. With over 6,500 procedures completed in less than two years, the rapid and positive effects of high-pressure cryotherapy are undeniable.

The unanimous fast-track approval by the AMA reflects the significance of this modality in the realm of pain management. Patients can have confidence in the safety and efficacy of high-pressure cryotherapy, knowing that it has been rigorously examined and endorsed by a trusted medical authority.

Join the Movement

The journey of New York Cryogen and Gregory Papageorge is not just a story of innovation; it is an invitation for patients, healthcare providers, and medical professionals to join a transformative movement. High-pressure medical cryotherapy has the potential to revolutionize pain management and change the lives of countless individuals in need of relief and healing.

The journey of New York Cryogen and the AMA endorsement of high-pressure cryotherapy is a beacon of hope and a source of motivation for anyone seeking pain relief and healing. It signals the dawn of a new era in pain management, where innovative solutions are reshaping the way we understand and treat pain.

Stay updated on their groundbreaking innovations by following New York Cryogen on Instagram (newyorkcryogen) and Facebook (New York Cryogen). Visit their website at www.nycryogen.comwww.ac130viper.com to learn more about their products and services.

 

Share this article

(Ambassador)

This article features branded content from a third party. Opinions in this article do not reflect the opinions and beliefs of The Wall Street Times.